News

Vaccines and conflicts of interest, Ricciardi's reply (Iss)

The president of the Higher Institute of Health answers the question of Article 1-Mdp and denounces Senator Vincenzo D'Anna (Ala) for defamation

Starting from 1 September 2015, the president of the Higher Institute of Health (ISS), simultaneously with taking over the leadership of the Institute, took leave of absence from the Catholic University and resigned from all the positions he had held up to then, including those compatible with the current one". Walter Ricciardi entrusts the reply to the allegations of alleged conflicts of interest raised by a parliamentary question presented in recent days by Articolo1-Mdp in a note released by the ISS.

In the text, first signed by Nerina Dirindin, clarifications are requested regarding a sponsorship by Merck Sharp & Dohme in favor of the Catholic University of Rome, of which Ricciardi was director, and reference is made to the role played by the ISS in the preparation of the new National Vaccine Plan and to Ricciardi's "technical-scientific support" for the preparation of the decree law 73/2017 on vaccines currently under discussion. The Five Star Movement had also intervened on the matter, asking for clarity "on a potential case of conflict of interest".

Ricciardi also announces legal initiatives against Senator Vincenzo D'Anna (Ala), who accused him last Wednesday at Palazzo Madama of "having taken 600,000 euros from Merck Sharp & Dohme to get paid for a professorship at the University". The president of the ISS has given a mandate to his lawyers to file a complaint for defamation. "The senator's statements are particularly serious since, in addition to harming the image and reputation of the president, they also damage the prestige and authority of the largest public health institute", concludes the ISS note.

Related news: On vaccines, the sleep of reason and the reason for sleep

Vaccines. Question by Art.1-Mdp on "potential" conflict of interest for Ricciardi

Mdp query

Riccardi appointment: Codacons, appeal to the Tar against President Mattarella's act

CS N°35/2017 – Statement by President Walter Ricciardi

ISS – Fact Checking Vaccines

Redazione Fedaiisf

Promote the cohesion and union of all members to allow a univocal and homogeneous vision of the professional problems inherent in the activity of pharmaceutical sales reps.

Articoli correlati

Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco